INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• How Do Site Payments Impact Clinical Trial Sustainability?

  Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

• How Emerging Technologies Are Challenging Traditional IRB Oversight

  Uncover how sponsors, CROs, and study monitors can navigate FDA expectations and Institutional Review Board (IRB) requirements when integrating AI and Software-as-a-Medical-Device into clinical trials.

• Fomenting A Culture Of Analytical Excellence In Clinical Development

  Building an "analytics culture" in clinical research requires striking a balance between fast, flexible technologies and the right support for trial teams working to integrate these solutions.

• Driving Customer Profitability With Enterprise Platform, Pricing

  Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.

• Aligning Wearable Data Collection Tith Visit Schedules Through EDC Integration

  9/11/2025

  Learn how integrating with an EDC system can streamline monitoring and improve data quality in multi-period trials.

• Clinical Leader Smart Sourcing Solutions Expo: Retention By Design

  9/9/2025

  Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.

• How Optina Diagnostics Used EDC In Earlier Disease Detection

  5/15/2024

  Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.

• Advancing Neuromuscular Research with Digital Endpoints

  1/20/2026

  Explore cutting-edge digital measures that capture peak mobility and activity in real-world settings, offering meaningful insights into disease progression in neuromuscular disorders.

• Drilling Down On Diversity And Feasibility

  12/8/2025

  A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.